Welcome to the 73rd BioCoherence public training webinar.

This session is a practical recap following the recent conference, with open discussion around what worked well, what created friction, and what needs to improve as BioCoherence continues to grow in real-world practitioner settings.

The team reflects on conference results, practitioner experiences, product questions, onboarding challenges, and the importance of making the system easier to explain, easier to sell, and easier for new users to begin with confidence.

Topics covered in this webinar include:
• Recap from the recent conference and practitioner feedback
• What happened at the BioCoherence table and what drew people in
• Real-world issues under pressure, including sensor readiness and playback friction
• Why BioCoherence often needs time, explanation, and guided experience
• The need for better educational tools, short videos, and clearer demonstrations
• Client onboarding flows and how to connect accounts properly
• Trial subscriptions, free practitioner quota, and invitation flow walkthrough
• Pricing confusion, public pricing, practitioner pricing, and the need for simpler price lists
• Harmonizer updates, licensing structure, and future pack offers
• Distributor and practitioner requests for simpler sales flows and dashboards
• Sharing the keynote presentation and using recorded materials for education and lead generation

This webinar is especially useful for distributors, practitioners, and anyone actively introducing BioCoherence to new clients. It gives a very honest look at the practical side of presenting the system in the field, handling questions, improving the user journey, and making the offer clearer for everyone involved.
Follow @biocoherenceapp on X/Twitter, Instagram, FaceBook, YouTube, TikTok
免責事項 BioCoherenceは、学術的分析とエネルギー的および実験的分析の両方を提供します。 表示される情報は、システムの物理的状態と相関している場合もあれば、そうでない場合もあります。 計算は、個々の測定値と実験アルゴリズムに基づいています。 エネルギーレベル、エントロピーレベル、コヒーレントシステムなど、すべての計算結果は、医療目的ではなく、個人の発展に役立つ情報を提供するように設計されています。すべての結果の使用は、ユーザーの単独の責任において行われます。疑問がある場合は、医師に相談することが重要です。使用を決定する前に、私たちのEULAを確認してください
O